PIs must complete an IBC Annual Renewal each year to continue work for up to three years after the initial approval. After three years, the application must be resubmitted and reviewed by the committee.

What needs IBC approval?

• Recombinant or synthetic nucleic acid molecules
• Hazardous biological agents (virus, bacteria, fungi, parasite, prion, rickettsia etc.)
• Other potentially infectious materials (human or non-human primate blood, serum, plasma, body fluids, unfixed tissue, organ and cells)
• Biological toxins including select agent toxins
• Inactivated Biological Samples derived from BSL-3 or BSL-4 agents
• Attenuated pathogens derived from BSL-3 or BSL-4 agents
• Human gene transfer
• Transgenic animals or plants

Forms

All protocol forms are now located in the IBC eCompliance module. This includes the application with embedded appendices, the Heptatitis B Acceptance/Declination Form, and the PI/Department Head Signature forms. 

https://umkc.ecompliance.umsystem.edu/ibc 

For guidance on submitting a protocol for review in eCompliance please review the following guidance document:

IBC eCompliance Resource Document

See NIH Guidelines (PDF) for additional information.